FDA speeds up review of Gilead's HIV drug

04:37 EDT 11 Aug 2017 | SmartBrief

Gilead Sciences' new-drug application for a fixed-dose combination of bictegravir 50 mg and emtricitabine/tenofovir alafenami -More

Original Article: FDA speeds up review of Gilead's HIV drug


More From BioPortfolio on "FDA speeds up review of Gilead's HIV drug"

Quick Search

Relevant Topics

Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...

Reverse Transcriptase
Reverse transcriptase (RT) is an enzyme used to generate complementary DNA (cDNA) from an RNA template, a process termed reverse transcription. It is mainly associated with retroviruses. RT inhibitors are widely used as antiretroviral drugs. RT activitie...